3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
12
Active not recruiting
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Myeloid
1
CNS
1
Conditions
Small Cell Lung Carcinoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large B-Cell, Diffuse
11
Lung Neoplasms
10
Burkitt Lymphoma
9
Leukemia, Myeloid, Acute
8
Lymphoma
7
Hodgkin Disease
6
Carcinoma, Non-Small-Cell Lung
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Sarcoma, Ewing
3
Sarcoma
3
Rhabdomyosarcoma
3
Rhabdoid Tumor
3
Retinoblastoma
3
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neuroblastoma
3
Neoplasms, Germ Cell and Embryonal
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia
3
Immunoblastic Lymphadenopathy
3
Seminoma
2
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
regorafenib
3
Specimen Handling
3
Nivolumab
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pembrolizumab
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
cabozantinib
2
Etoposide
2
Docetaxel
2
tocilizumab
1
tazemetostat
1
poly ICLC
1
palbociclib
1
naxitamab
1
mifamurtide
1
humanized 3F8 anti-GD2 monoclonal antibody
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Osteosarcoma
×
Etoposide
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled